다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Ovid Therapeutics Inc (OVID)
Ovid Therapeutics Inc (OVID) 뉴스

OVID

Ovid Therapeutics (OVID)

Ovid Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OVID

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	06:19	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:OVID	Ovid Therapeutics Inc
2024/05/14	21:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OVID	Ovid Therapeutics Inc
2024/05/14	21:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/05/14	21:00	GlobeNewswire Inc.	Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results	NASDAQ:OVID	Ovid Therapeutics Inc
2024/05/13	20:00	GlobeNewswire Inc.	Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference	NASDAQ:OVID	Ovid Therapeutics Inc
2024/04/04	21:00	GlobeNewswire Inc.	Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:OVID	Ovid Therapeutics Inc
2024/03/08	22:24	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:OVID	Ovid Therapeutics Inc
2024/03/08	22:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/03/08	22:00	GlobeNewswire Inc.	Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:OVID	Ovid Therapeutics Inc
2024/02/28	22:00	GlobeNewswire Inc.	Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	NASDAQ:OVID	Ovid Therapeutics Inc
2024/02/27	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/02/27	08:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/02/27	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/02/27	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/02/27	07:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/02/15	01:10	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:OVID	Ovid Therapeutics Inc
2024/02/12	20:06	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:OVID	Ovid Therapeutics Inc
2024/02/06	22:00	GlobeNewswire Inc.	Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:OVID	Ovid Therapeutics Inc
2023/12/07	07:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2023/12/01	21:30	GlobeNewswire Inc.	Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)	NASDAQ:OVID	Ovid Therapeutics Inc
2023/11/16	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:OVID	Ovid Therapeutics Inc
2023/11/16	06:11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:OVID	Ovid Therapeutics Inc
2023/11/04	05:08	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:OVID	Ovid Therapeutics Inc
2023/11/03	21:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OVID	Ovid Therapeutics Inc
2023/11/03	21:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2023/11/03	21:00	GlobeNewswire Inc.	Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates	NASDAQ:OVID	Ovid Therapeutics Inc
2023/10/18	21:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2023/10/18	21:00	GlobeNewswire Inc.	Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026	NASDAQ:OVID	Ovid Therapeutics Inc
2023/10/10	21:00	GlobeNewswire Inc.	Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit	NASDAQ:OVID	Ovid Therapeutics Inc
2023/10/03	01:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc

검색 관련기사 보기:NASDAQ:OVID

1 2 3 4 5 6 7 8 9 10 다음 >>

US Dollar vs Euro

American Express

US Dollar vs Yen

Gold vs US Dollar

Bank of America

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관